OĞUZMAN, S. Et Al. 2022. Evaluation of Patients with Chronic Immune Thrombocytopenic Purpura Treated with Eltrombopag: A Single Center Experience. ACTA ONCOLOGICA TURCICA , vol.55, no.2 , 159-164.

OĞUZMAN, S., TEKE, H. U., ANDIÇ, N., & GUNDUZ, E., (2022). Evaluation of Patients with Chronic Immune Thrombocytopenic Purpura Treated with Eltrombopag: A Single Center Experience. ACTA ONCOLOGICA TURCICA , vol.55, no.2, 159-164.

OĞUZMAN, SEDANUR Et Al. "Evaluation of Patients with Chronic Immune Thrombocytopenic Purpura Treated with Eltrombopag: A Single Center Experience," ACTA ONCOLOGICA TURCICA , vol.55, no.2, 159-164, 2022

OĞUZMAN, SEDANUR Et Al. "Evaluation of Patients with Chronic Immune Thrombocytopenic Purpura Treated with Eltrombopag: A Single Center Experience." ACTA ONCOLOGICA TURCICA , vol.55, no.2, pp.159-164, 2022

OĞUZMAN, S. Et Al. (2022) . "Evaluation of Patients with Chronic Immune Thrombocytopenic Purpura Treated with Eltrombopag: A Single Center Experience." ACTA ONCOLOGICA TURCICA , vol.55, no.2, pp.159-164.

@article{article, author={SEDANUR OĞUZMAN Et Al. }, title={Evaluation of Patients with Chronic Immune Thrombocytopenic Purpura Treated with Eltrombopag: A Single Center Experience}, journal={ACTA ONCOLOGICA TURCICA}, year=2022, pages={159-164} }